Diagnostic Substance Business Investment Opportunities

• Manufacturer of blood-based diagnostic kits for infectious diseases including HIV, HBsAg, syphilis, hepatitis B, and hepatitis C. • Operates from a licensed drug manufacturing facility, ensuring regulatory compliance and product reliability. Holds a valid drug license. • Supplies diagnostic kits primarily to healthcare providers, hospitals, and diagnostic laboratories through an established distribution network. • Works with 200+ distributors, enabling broad market reach and consistent product availability. • Installed manufacturing capacity of 25,000–30,000 kits per month, currently operating at 30–40% utilization, offering significant headroom for scale. • Focused on essential, high-demand diagnostic categories with recurring institutional demand. • Family-owned business with hands-on operational oversight and industry continuity. • Positioned to scale production and expand distribution with existing infrastructure and regulatory approvals in place.

• Manufacturer of blood-based diagnostic kits for infectious diseases including HIV, HBsAg, syphilis, hepatitis B, and hepatitis C. • Operates from a licensed drug manufacturing facility, ensuring regulatory compliance and product reliability. Holds a valid drug license. • Supplies diagnostic kits primarily to healthcare providers, hospitals, and diagnostic laboratories through an established distribution network. • Works with 200+ distributors, enabling broad market reach and consistent product availability. • Installed manufacturing capacity of 25,000–30,000 kits per month, currently operating at 30–40% utilization, offering significant headroom for scale. • Focused on essential, high-demand diagnostic categories with recurring institutional demand. • Family-owned business with hands-on operational oversight and industry continuity. • Positioned to scale production and expand distribution with existing infrastructure and regulatory approvals in place.